Log in using OpenID

Global Glaucoma Therapeutics Market 2014-2018

Big Market Research present “Global Glaucoma Therapeutics Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @
Global Glaucoma Therapeutics Market 2014-2018
Market , Share, Size, Trends, Analysis, Demand & Forecast to
Report Description:
About Glaucoma Therapeutics
Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left
untreated the patient may lose vision and even become blind. The exact etiology of optic nerve
damage due to glaucoma is not fully known, but involves mechanical compression and/or
decreased blood flow in the optic nerve. Based on whether the cause of the disease is
unknown or known, glaucoma is divided into two types, open angle and closed angle
glaucoma. Five main classes of medical treatment are currently used to lower intraocular
pressure: prostaglandins, beta blockers, alpha adrenergic agonists, carbonic anhydrase
inhibitors, and fixed dose combinations.
The Global Glaucoma Therapeutics market will grow at a CAGR of 2.53 percent over the
period 2013-2018.
About Report:
Report Description:
Covered in this Report
The Global Glaucoma Therapeutics market can be divided into five segments: Prostaglandins,
Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, and Fixed Dose
Combinations. To calculate the market size, the report considers the revenue generated from
the sales of various ophthalmic solutions used in the treatment of glaucoma.
Global Glaucoma Therapeutics Market 2014-2018, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the Americas and the
EMEA and APAC regions; it also covers the Global Glaucoma Therapeutics market landscape
and its growth prospects in the coming years. The report also includes a discussion of the key
vendors operating in this market.
Key Regions
• Americas
Key Regions:
Key Vendors
• Allergan Inc.
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
Other Prominent Vendors
• Acadia Pharmaceuticals Inc.
• AC Immune SA
• Acorn Biomedical Inc.
• Advanced Cell Technology Inc.
• Aerie Pharmaceuticals Inc.
• Carl Zeiss Meditec Inc.
• Falcon Pharmaceuticals Ltd.
• Inotek Pharmaceuticals Corp.
• Lexicon Pharmaceuticals Inc.
• Neurotech Pharmaceuticals Inc.
Key Regions:
Key Market Driver
• Increasing Prevalence of Eye Disorders.
• For a full, detailed list, view our report.
Key Market Challenge
• Increasing Number of Patent Expirations.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in Awareness of Glaucoma.
• For a full, detailed list, view our report.
Key Regions:
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Visit us at :
Stay With Us:
TELEPHONE: + 1-800-910-6452
[email protected]
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Report inappropriate content